Antibiofilm Effect of Lavandula multifida Essential Oil: A New Approach for Chronic Infections
Pharmaceutics · 15.08.2023 · 15 (8) · 2142
DOI: 10.3390/pharmaceutics15082142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 15.08.2023. Verfasst von Jorge Alves-Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Univ Coimbra, Faculty of Pharmacy, Azinhaga de S. Comba, 3000-548 Coimbra, Portugal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: La Caixa Foundation and Foundation for Science and Technology, PPBI-Portuguese Platform of BioImaging.
Abstract (Originalsprache)
Fungal infections are associated with high morbidity and mortality rates, being highly prevalent in patients with underlying health complications such as chronic lung disease, HIV, cancer, and diabetes mellitus. To mitigate these infections, the development of effective antifungals is imperative, with plants standing out as promising sources of bioactive compounds. In the present study, we focus on the antibiofilm potential of Lavandula multifida essential oil (EO) against dermatophyte strains and Candida albicans. The EO was characterized using GC and GC–MS, and its antifungal effect was assessed on both biofilm formation and disruption. Biofilm mass, extracellular matrix, and viability were quantified using crystal violet, safranin, and XTT assays, respectively, and morphological alterations were confirmed using optical and scanning electron microscopy. L. multifida EO showed very high amounts of carvacrol and was very effective in inhibiting and disrupting fungal biofilms. The EO significantly decreased biofilm mass and viability in all tested fungi. In addition, a reduction in dermatophytes’ extracellular matrix was observed, particularly during biofilm formation. Morphological alterations were evident in mature biofilms, with a clear decrease in hypha diameter. These promising results support the use of L. multifida EO in the development of effective plant-based antifungal products.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Univ Coimbra, Faculty of Pharmacy, Azinhaga de S. Comba, 3000-548 Coimbra, Portugal.
- Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, Azinhaga de S. Comba, 3000-548 Coimbra, Portugal.
- Univ Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), 3000-548 Coimbra, Portugal.
- Clinical Academic Centre of Coimbra (CACC), 3004-561 Coimbra, Portugal.
- Univ Coimbra, Chemical Process Engineering and Forest Products Research Centre (CIEPQPF), Department of Chemical Engineering, Faculty of Sciences and Technology, Rua Sílvio Lima, 3030-790 Coimbra, Portugal.
ORCID-Profile: Jorge Alves-Silva, Mónica Zuzarte, Carlos Cavaleiro, Lígia Salgueiro
Förderung
- La Caixa Foundation and Foundation for Science and Technology
- PPBI-Portuguese Platform of BioImaging
Zitieren
APA
Alves-Silva, J., Zuzarte, M., Cavaleiro, C., & Salgueiro, L. (2023). Antibiofilm Effect of Lavandula multifida Essential Oil: A New Approach for Chronic Infections. Pharmaceutics, 15(8), 2142. https://doi.org/10.3390/pharmaceutics15082142
Vancouver
Alves-Silva J, Zuzarte M, Cavaleiro C, Salgueiro L. Antibiofilm Effect of Lavandula multifida Essential Oil: A New Approach for Chronic Infections. Pharmaceutics. 2023;15(8):2142. doi:10.3390/pharmaceutics15082142
BibTeX
@article{AlvesSilva2023,
author = {Alves-Silva, Jorge and Zuzarte, Mónica and Cavaleiro, Carlos and Salgueiro, Lígia},
title = {Antibiofilm Effect of Lavandula multifida Essential Oil: A New Approach for Chronic Infections},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {8},
pages = {2142},
doi = {10.3390/pharmaceutics15082142}
}
EUVIMED